Platform Therapeutics, Inc.
PrivateLast Round
Seed
Aug 27, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Platform Therapeutics, Inc. is a clinical-stage life-science company that develops therapies to mitigate the toxic effects of chemotherapy and alleviate muscle cramps during dialysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Platform Therapeutics, Inc. Comparables
Compare Platform Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ting Therapeutics | 77% | |
| Acousia Therapeutics GmbH | 76% | |
| Regeneron Pharmaceuticals | 74% |
Platform Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 27, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2026
Raised $1.75M in a Seed Round.
Platform Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Platform Therapeutics, Inc.'s valuation, stock price, and market status.
Is Platform Therapeutics, Inc. a public or private company?
Platform Therapeutics, Inc. is a private company.
What is the current stock price of Platform Therapeutics, Inc.?
Platform Therapeutics, Inc. is a private company with no public stock price. Caplight tracks Platform Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Platform Therapeutics, Inc. worth (valuation)?
Valuation information for Platform Therapeutics, Inc. is not publicly available.
Can I buy Platform Therapeutics, Inc. stock?
Platform Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Platform Therapeutics, Inc.'s last funding round?
Platform Therapeutics, Inc.'s most recent funding round was Seed Round on August 27, 2026.
Who are the main investors in Platform Therapeutics, Inc.?
Investor information for Platform Therapeutics, Inc. is not publicly disclosed.
Will Platform Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Platform Therapeutics, Inc..
How can I track Platform Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Platform Therapeutics, Inc.'s secondary market activity and sign up for updates.